Colgate-Palmolive (India) (500830) Q4 97/98 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 97/98 earnings summary
19 Oct, 2026Executive summary
FY1997-98 gross sales reached Rs 989.07 crore vs Rs 960.60 crore; net sales rose to Rs 945.91 crore from Rs 904.54 crore, while profit after tax was Rs 80.07 crore vs Rs 78.93 crore.
Competitive pressure and sluggish consumer demand prompted higher advertising investment and launches of Colgate Double Protection and Colgate Total.
Strategic investments included a Nepal manufacturing facility, Powai research centre, SAP system, Dicalcium Phosphate production and a regional distribution centre.
Financial highlights
Profit before tax was Rs 127.01 crore vs Rs 143.93 crore; profit after tax was Rs 80.07 crore vs Rs 78.93 crore.
Other income was Rs 16.28 crore vs Rs 17.62 crore; total income was Rs 1,005.35 crore vs Rs 978.21 crore.
Materials cost declined to Rs 530.90 crore from Rs 542.01 crore; other expenses increased to Rs 252.31 crore from Rs 192.43 crore.
Gross sales were Rs 989.07 crore vs Rs 960.60 crore; sales net of excise were Rs 945.91 crore vs Rs 904.54 crore.
Outlook and guidance
Consumer-goods demand remained sluggish amid a continuing industrial slowdown and lower agricultural production.
The Board expected investments in products, research, technology and distribution to strengthen long-term competitiveness and operations.
Colgate-Palmolive (Nepal) began commercial production in July 1998; SAP went live the same month, with benefits expected from progressive implementation.
Latest events from Colgate-Palmolive (India)
- Q2 sales rose 12.2%, gross margin reached 69.6%, and adjusted PAT grew 5.5%.500830
Q2 26/27 - Sales grew 16.5%, but excise-related inventory costs constrained profit growth.500830
Q4 96/97 - Profit fell amid weak demand, while product launches and capacity expansion positioned growth.500830
Q4 98/99 - Sales rose 12% and adjusted profit 23% despite a depressed FMCG market.500830
Q4 99/00 - Profit rose 27% despite falling sales as product renewal offset market headwinds.500830
Q4 02/03 - Sales and profit advanced on launches and cash generation despite weak demand.500830
Q4 00/01 - Profit rose 22% as price cuts revived toothpaste demand and capacity expansion advanced.500830
Q4 03/04 - Profit rose 12% on flat sales, despite a major depreciation charge.500830
Q4 01/02 - Sales rose 17%, record profit grew 21%, and Nepal toothpaste production ended.500830
Q4 05/06